Building Once, Validating Forever: Why Scalable CQV Is the Future-Proof Strategy Life Sciences Manufacturers Can’t Ignore – Scalability is the difference between a validation program that becomes a growing liability and one that becomes a strategic asset as your operation expands.
Navigating the Pitfalls of MSAT for Successful Technology Transfer: In the biopharmaceutical sector, MS&T responsibilities extend to both upstream and downstream processes. This includes optimizing cell culture conditions, managing bioreactor performance, and ensuring effective purification